Factors Leading Patients to Discontinue Multiple Sclerosis Therapies
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Pharmacy,Pharmacology (nursing)
Reference13 articles.
1. Disease modifying therapies in multiple sclerosis. Report of the therapeutics and technology assessment subcommittee of the American Academy ofNeurology and the MS Council for Clinical Practice Guidelines;Goodin;Neurology,2002
2. Multiple sclerosis;Bainbridge,2002
3. Placebo-controlled multicentre randomised trial of interferon beta- 1b in treatment of secondary progressive multiple sclerosis;European Study Group on Interferon Beta-1b in Secondary Progressive MS;Lancet.,1998
4. Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6years;Johnson;Mult Scler.,2000
5. Rebif (interferon-beta 1a) [package insert],2003
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Adherence and persistence to self-administered disease-modifying therapies in patients with multiple sclerosis: A multisite analysis;Multiple Sclerosis and Related Disorders;2023-07
2. Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis;Neurology and Therapy;2022-11-05
3. Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 Study;Advances in Therapy;2022-02-24
4. Adherence to and Persistence with Disease-Modifying Therapies for Multiple Sclerosis Over 24 Months: A Retrospective Claims Analysis;Neurology and Therapy;2022-01-12
5. A Novel Digital Care Management Platform to Monitor Clinical and Subclinical Disease Activity in Multiple Sclerosis;Brain Sciences;2021-09-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3